Genome-Wide/NN
Association/NN
Studies/NNS
of/IN
the/DT
Korea/NN
Association/NN
REsource/NN
(/(
KARE/NN
)/)
Consortium/NN
./.
====================
During/IN
the/DT
last/JJ
decade/NN
,/,
large/JJ
community/NN
cohorts/NNS
have/VBP
been/VBN
established/VBN
by/IN
the/DT
Korea/NN
National/JJ
Institutes/NNS
of/IN
Health/NN
(/(
KNIH/NN
)/)
,/,
and/CC
enormous/JJ
epidemiological/JJ
and/CC
clinical/JJ
data/NNS
have/VBP
been/VBN
accumulated/VBN
./.
====================
Using/VBG
these/DT
information/NN
and/CC
samples/NNS
in/IN
the/DT
cohorts/NNS
,/,
KNIH/NN
set/NN
out/RP
to/TO
do/VBP
a/DT
large-scale/JJ
genome-wide/NN
association/NN
study/NN
(/(
GWAS/NN
)/)
in/IN
2007/CD
,/,
and/CC
the/DT
Korea/NN
Association/NN
REsource/NN
(/(
KARE/NN
)/)
consortium/NN
was/VBD
launched/VBN
to/TO
analyze/VB
the/DT
data/NNS
to/TO
identify/VB
the/DT
underlying/VBG
genetic/JJ
risk/NN
factors/NNS
of/IN
diseases/NNS
and/CC
diverse/JJ
health/NN
indexes/NNS
,/,
such/JJ
as/IN
blood/NN
pressure/NN
,/,
obesity/NN
,/,
bone/NN
density/NN
,/,
and/CC
blood/NN
biochemical/JJ
traits/VBZ
./.
====================
The/DT
consortium/NN
consisted/VBD
of/IN
6/CD
research/NN
divisions/NNS
,/,
formed/VBD
by/IN
25/CD
principal/JJ
investigators/NNS
in/IN
19/CD
organizations/NNS
,/,
including/VBG
18/CD
universities/NNS
,/,
2/CD
institutes/NNS
,/,
and/CC
1/CD
company/NN
./.
====================
Each/DT
division/NN
focused/VBN
on/IN
one/CD
of/IN
the/DT
following/VBG
subjects/NNS
:/:
the/DT
identification/NN
of/IN
genetic/JJ
factors/NNS
,/,
the/DT
statistical/JJ
analysis/NN
of/IN
gene-gene/JJ
interactions/NNS
,/,
the/DT
genetic/JJ
epidemiology/NN
of/IN
gene-environment/JJ
interactions/NNS
,/,
copy/NN
number/NN
variation/NN
,/,
the/DT
bioinformatics/NNS
related/JJ
to/TO
a/DT
GWAS/JJ
,/,
and/CC
a/DT
GWAS/JJ
of/IN
nutrigenomics/NNS
./.
====================
In/IN
this/DT
special/JJ
issue/NN
,/,
the/DT
study/NN
results/VBZ
of/IN
the/DT
KARE/NN
consortium/NN
are/VBP
provided/VBN
as/IN
9/CD
articles/NNS
./.
====================
We/PRP
hope/VBP
that/DT
this/DT
special/JJ
issue/NN
might/MD
encourage/VB
the/DT
genomics/NNS
community/NN
to/TO
share/VB
data/NNS
and/CC
scientists/NNS
,/,
including/VBG
clinicians/NNS
,/,
to/TO
analyze/VB
the/DT
valuable/JJ
Korean/JJ
data/NNS
of/IN
KARE/NN
./.
====================
Most/JJS
common/JJ
diseases/NNS
are/VBP
influenced/VBN
by/IN
multiple/JJ
genetic/JJ
factors/NNS
as/IN
well/RB
as/IN
environmental/JJ
factors/NNS
./.
====================
However/RB
,/,
each/DT
single/JJ
genetic/JJ
effect/NN
might/MD
contribute/VB
a/DT
small/JJ
part/NN
to/TO
the/DT
phenotype/NN
./.
====================
Therefore/RB
,/,
large/JJ
sample/JJ
sizes/NNS
and/CC
genomewide/NN
analysis/NN
are/VBP
necessary/JJ
to/TO
identify/VB
multiple/JJ
genetic/JJ
factors/NNS
./.
====================
Since/IN
2001/CD
,/,
the/DT
Korea/NN
National/JJ
Institute/JJ
of/IN
Health/NN
(/(
KNIH/NN
)/)
has/VBZ
established/VBN
cohorts/NNS
nationwide/NN
and/CC
accumulated/VBD
epidemiological/JJ
and/CC
clinical/JJ
information/NN
on/IN
a/DT
large/JJ
scale/JJ
,/,
up/IN
to/TO
300,000/CD
subjects/NNS
./.
====================
Using/VBG
these/DT
samples/NNS
,/,
KNIH/NN
set/NN
to/TO
produce/VB
genotype/NN
data/NNS
in/IN
2007/CD
and/CC
proceeded/VBD
to/TO
perform/VB
a/DT
genomewide/NN
association/NN
study/NN
(/(
GWAS/NN
)/)
./.
====================
In/IN
order/NN
to/TO
make/VB
the/DT
most/JJS
of/IN
the/DT
massive/JJ
phenotype/NN
and/CC
genotype/NN
data/NNS
set/VBP
,/,
the/DT
extramural/JJ
research/NN
consortium/NN
was/VBD
organized/VBN
to/TO
host/NN
scientists/NNS
interested/JJ
in/IN
these/DT
data/NNS
./.
====================
The/DT
Korea/NN
Association/NN
REsource/NN
(/(
KARE/NN
)/)
consortium/NN
consists/VBZ
of/IN
6/CD
research/NN
divisions/NNS
,/,
formed/VBD
by/IN
25/CD
principal/JJ
investigators/NNS
in/IN
19/CD
organizations/NNS
,/,
including/VBG
18/CD
universities/NNS
,/,
2/CD
institutes/NNS
,/,
and/CC
1/CD
company/NN
./.
====================
Each/DT
division/NN
focused/VBN
on/IN
one/CD
of/IN
following/VBG
subjects/NNS
:/:
the/DT
identification/NN
of/IN
genetic/JJ
factors/NNS
,/,
the/DT
statistical/JJ
analysis/NN
of/IN
genegene/JJ
interactions/NNS
,/,
the/DT
genetic/JJ
epidemiology/NN
of/IN
geneenvironment/JJ
interactions/NNS
,/,
copy/NN
number/NN
variation/NN
,/,
bioinformatics/NNS
related/JJ
to/TO
GWAS/JJ
,/,
and/CC
a/DT
GWAS/JJ
of/IN
nutrigenomics/NNS
./.
====================
In/IN
this/DT
issue/NN
,/,
9/CD
papers/NNS
were/VBD
selected/VBN
from/IN
the/DT
consortium/NN
./.
====================
Hong/JJ
et/FW
al/JJ
./.
====================
(/(
2010/CD
)/)
investigated/VBD
the/DT
feasibility/NN
of/IN
using/VBG
imputed/JJ
SNPs/NNS
for/IN
a/DT
GWAS/JJ
with/IN
blood/NN
pressure/NN
traits/VBZ
to/TO
determine/VB
whether/IN
they/PRP
could/MD
improve/VB
the/DT
previous/JJ
results/NNS
that/IN
were/VBD
analyzed/VBN
without/IN
imputation/NN
(/(
Cho/NNP
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
Park/NN
et/FW
al/JJ
./.
====================
(/(
2010/CD
)/)
performed/VBN
a/DT
GWAS/JJ
for/IN
blood/NN
pressure/NN
with/IN
3/CD
different/JJ
phenotype/NN
models/NNS
:/:
young/JJ
hypertensive/JJ
cases/NNS
versus/CC
elderly/JJ
normotensive/JJ
controls/NNS
,/,
the/DT
upper/JJ
25/CD
%/NN
versus/CC
the/DT
lower/JJR
25/CD
%/NN
of/IN
SBP/NN
distribution/NN
,/,
and/CC
SBP/NN
and/CC
DBP/NN
as/IN
continuous/JJ
traits/VBZ
./.
====================
Kim/NN
et/FW
al/JJ
./.
====================
(/(
2010c/JJ
)/)
conducted/VBD
a/DT
GWAS/JJ
for/IN
hematological/JJ
parameters/NNS
using/VBG
copy/NN
number/NN
variations/NNS
./.
====================
Kwon/NN
and/CC
Kim/NN
(/(
2010/CD
)/)
analyzed/VBD
a/DT
GWAS/JJ
for/IN
3/CD
erythrocyte/NN
traits/VBZ
,/,
such/JJ
as/IN
hemoglobin/NN
,/,
hematocrit/NN
,/,
and/CC
red/JJ
blood/NN
cells/NNS
./.
====================
Doo/RB
and/CC
Kim/NN
(/(
2010/CD
)/)
conducted/VBD
an/DT
association/NN
study/NN
between/IN
an/DT
ADIPOQ/NN
gene/NN
SNP/NN
(/(
rs182052/NN
)/)
and/CC
obesity/NN
in/IN
Korean/JJ
women/NNS
./.
====================
Kim/NN
et/FW
al/JJ
./.
====================
(/(
2010b/NN
)/)
compared/VBD
the/DT
Affymetrix/JJ
SNP/NN
array/NN
5.0/CD
and/CC
oligoarray/NN
platforms/NNS
for/IN
defining/VBG
copy/NN
number/NN
variation/NN
./.
====================
Oh/DT
et/FW
al/JJ
./.
====================
(/(
2010/CD
)/)
applied/VBD
a/DT
joint/NN
identification/NN
approach/NN
to/TO
largescale/JJ
GWA/NN
data/NNS
in/IN
order/NN
to/TO
identify/VB
genetic/JJ
variants/NNS
of/IN
obesity/NN
for/IN
the/DT
Korean/JJ
population/NN
./.
====================
Kim/NN
et/FW
al/JJ
./.
====================
(/(
2010a/CD
)/)
applied/VBD
a/DT
structural/JJ
equation/NN
model/NN
to/TO
a/DT
GWAS/JJ
for/IN
the/DT
following/VBG
two/CD
purposes/NNS
:/:
to/TO
model/VB
a/DT
complex/JJ
relationship/NN
between/IN
a/DT
genetic/JJ
network/NN
and/CC
traits/VBZ
as/IN
risk/NN
factors/NNS
and/CC
to/TO
achieve/VB
a/DT
better/RBR
understanding/NN
of/IN
the/DT
biological/JJ
mechanism/NN
through/IN
not/RB
only/RB
a/DT
single/JJ
gene/NN
but/CC
also/RB
many/JJ
genes/NNS
involved/VBN
in/IN
the/DT
pathway/NN
of/IN
the/DT
trait/NN
./.
====================
Kim/NN
et/FW
al/JJ
./.
====================
(/(
2010d/CD
)/)
conducted/VBD
targeted/VBN
resequencing/VBG
of/IN
loci/NNS
identified/VBD
by/IN
the/DT
KARE/NN
GWAS/NN
to/TO
detect/VB
potential/JJ
casual/JJ
and/or/CC
rare/JJ
variants/NNS
for/IN
complex/NN
traits/VBZ
,/,
such/JJ
as/IN
type/NN
2/CD
diabetes/NNS
and/CC
triglycerides/VBZ
./.
====================
During/IN
the/DT
last/JJ
2/CD
years/NNS
of/IN
the/DT
consortium/NN
,/,
there/EX
have/VBP
been/VBN
more/RBR
than/IN
15/CD
meetings/NNS
and/CC
gatherings/NNS
to/TO
present/JJ
and/CC
discuss/VBP
results/NNS
of/IN
the/DT
KARE/NN
data/NNS
analysis/NN
./.
====================
Up/IN
to/TO
100/CD
participants/NNS
were/VBD
involved/VBN
in/IN
the/DT
discussions/NNS
,/,
establishing/VBG
a/DT
new/JJ
paradigm/NN
of/IN
science/NN
in/IN
genomics/NNS
in/IN
Korea/NN
./.
====================
The/DT
events/NNS
would/MD
not/RB
have/VB
been/VBN
possible/JJ
had/VBD
KNIH/NN
decided/VBD
not/RB
to/TO
make/VB
the/DT
valuable/JJ
data/NNS
open/JJ
to/TO
the/DT
consortium/NN
./.
====================
As/IN
members/NNS
of/IN
the/DT
consortium/NN
,/,
we/PRP
appreciate/VBP
the/DT
members/NNS
of/IN
the/DT
Center/JJ
for/IN
Genome/NN
Science/NNP
in/IN
KNIH/NN
,/,
the/DT
Ansung/JJ
and/CC
Ansan/NN
epidemiological/JJ
cohorts/NNS
,/,
and/CC
DNALink/NN
for/IN
producing/VBG
and/CC
managing/VBG
such/JJ
enormous/JJ
and/CC
valuable/JJ
resources/VBZ
./.
====================
Lastly/RB
,/,
we/PRP
hope/VBP
to/TO
apply/RB
these/DT
investigations/NNS
to/TO
better/RBR
serve/VBP
the/DT
health/NN
of/IN
the/DT
participants/NNS
in/IN
the/DT
cohorts/NNS
./.
====================
